|
A Prognostic Test for Early-Stage Breast Lesions
Subtitle
Image*
https://uc.technologypublisher.com/files/sites/118018_image-20221214131558-4.png
Description*
Dr. Georg F. Weber, Professor in the College of Pharmacy has developed a test to determine the risk for pre-malignant lesions to turn into breast cancer. This novel assessment utilizes variants of the progression mediator osteopontin...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Georg Weber
Keywords(s): Biological Assessment, Diagnostic Testing, Early-Stage Breast Lesions, Healthcare, Osteopontin Variants
Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Life Sciences
|